Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Fulcrum Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +20 vs. Q3 2023
- Shares held
- 61.1M
- +4.69M (+8.3%) vs. Q3 2023
- Total value
- $412.3M
- +$161.9M (+64.7%) vs. Q3 2023
- New holders
- 31
- 24 more added
- Sold out
- 11
- 21 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FULC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $291.3M |
| Q1 2026 | 169 | $550.1M |
| Q4 2025 | 172 | $762.7M |
| Q3 2025 | 129 | $494.9M |
| Q2 2025 | 122 | $374.5M |
| Q1 2025 | 117 | $147.8M |
| Q4 2024 | 119 | $243.4M |
| Q3 2024 | 130 | $196.4M |
| Q2 2024 | 121 | $402.0M |
| Q1 2024 | 126 | $569.7M |
| Q4 2023 | 101 | $412.3M |
| Q3 2023 | 81 | $250.4M |
| Q2 2023 | 88 | $183.2M |
| Q1 2023 | 116 | $172.2M |
| Q4 2022 | 110 | $368.5M |
| Q3 2022 | 105 | $422.1M |
| Q2 2022 | 102 | $196.6M |
| Q1 2022 | 108 | $929.9M |
| Q4 2021 | 110 | $657.3M |
| Q3 2021 | 101 | $1.03B |
| Q2 2021 | 67 | $280.8M |
| Q1 2021 | 68 | $317.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Fulcrum Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 11,609,704 | $78.4M | 1.22% | 00.0% | Unchanged |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −520,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −196,488−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −91,790−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −87,372−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −58,900−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −52,734−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −38,918−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −25,424−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −19,212−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −11,845−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −10,747−100.0% | Sold out |